Lifelong Learning in Immunology

Driven by unmet need, and guided by actionable science, we are inspired to change the course of such diseases by advancing and delivering transformational therapies.

Roughly 1 in 10 people around the world are living with immune-mediated diseases, including atopic dermatitis or eczema, inflammatory bowel disease (Crohn’s disease and ulcerative colitis), psoriatic disease (psoriasis and psoriatic arthritis), and a number of allo- and autoantibody diseases that fall into the rare, rheumatic and maternal fetal segments of disease. Among this population, only a fraction receive advanced therapies that effectively treat these conditions.